Pelthos Therapeutics Inc. (PTHS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $23.32
• 52-Week High: $37.50
• 52-Week Low: $9.00

About Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc. is a biotechnology company headquartered in Durham, North Carolina, dedicated to the development and commercialization of groundbreaking therapeutic solutions for significant unmet medical needs. Utilizing advanced biopharmaceutical technologies and innovative research, Pelthos strives to improve the lives of patients facing complex health challenges. With a strong focus on pioneering treatments, the company is strategically positioned to capitalize on growth opportu...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pelthos Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PTHS pay dividends?

Pelthos Therapeutics Inc. (PTHS) does not currently pay a regular dividend.